| pubmed-article:21401731 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21401731 | lifeskim:mentions | umls-concept:C0013018 | lld:lifeskim |
| pubmed-article:21401731 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
| pubmed-article:21401731 | lifeskim:mentions | umls-concept:C0018595 | lld:lifeskim |
| pubmed-article:21401731 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:21401731 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21401731 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21401731 | pubmed:dateCreated | 2011-5-3 | lld:pubmed |
| pubmed-article:21401731 | pubmed:abstractText | Haptoglobin (Hp) is a polymorphic plasma protein with multiple functions defined by three major phenotypes (Hp 1-1, Hp 2-1, and Hp 2-2). In this article, the effects of the donor Hp phenotype (determined by starch gel electrophoresis) on the outcome and the iron status after liver transplantation were investigated. A total of 450 liver transplant patients were enrolled in this study with a median follow-up of 37 months. Kaplan-Meier and Cox regression survival analyses showed a significantly worse graft survival for liver transplantation cases with an Hp 2-2 donor phenotype, which was associated with an increased mortality rate in this group. In male patients, the Hp 2-2 phenotype was associated with higher serum ferritin concentrations, which may be linked to the significantly increased likelihood of infectious complications in this phenotype. Liver transplant patients with Hp 1-1 and Hp 2-1 grafts had a better outcome probability than recipients of an Hp 2-2 graft, which may be explained by differences in iron metabolism induced by the Hp genotype of the graft. | lld:pubmed |
| pubmed-article:21401731 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21401731 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21401731 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21401731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21401731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21401731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21401731 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21401731 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21401731 | pubmed:issn | 1432-2277 | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:DelangheJoris... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:TroisiRoberto... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:SpeeckaertMar... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:SpeeckaertRei... | lld:pubmed |
| pubmed-article:21401731 | pubmed:author | pubmed-author:ClaeysLutgard... | lld:pubmed |
| pubmed-article:21401731 | pubmed:copyrightInfo | © 2011 The Authors. Transplant International © 2011 European Society for Organ Transplantation. | lld:pubmed |
| pubmed-article:21401731 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21401731 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:21401731 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21401731 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21401731 | pubmed:pagination | 619-26 | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:meshHeading | pubmed-meshheading:21401731... | lld:pubmed |
| pubmed-article:21401731 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21401731 | pubmed:articleTitle | Donor haptoglobin phenotype determines outcome following liver transplantation. | lld:pubmed |
| pubmed-article:21401731 | pubmed:affiliation | Department of Clinical Chemistry, Ghent University Hospital, De Pintelaan 85, Gent, Belgium. | lld:pubmed |
| pubmed-article:21401731 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3240 | entrezgene:pubmed | pubmed-article:21401731 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21401731 | lld:entrezgene |
